17511	LRECUR:2440	982		PUNCT:2:886:-96	CA:2034:914:-68	STAGE:2041:963:-19	PUNCT:2:971:-11	RISK:604:973:-9	DLOC:2161:991:9	ADTRIG:1020:1017:35	DOT:1:1046:64	6**], well knownto the Thoracic oncology group after treatment for a previousRUL Stage 3a, possibly Stage 3b NSCLCa (?SCCa) with almostcomplete response 4 years ago.  His functional status did notallow for su
